14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ABIO stock ended at $3.36. This is 2.13% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.81% from a day low at $3.27 to a day high of $3.46.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical ARCA biopharma prices

Date Open High Low Close Volume
Apr 05, 2022 $2.36 $2.39 $2.22 $2.31 176 600
Apr 04, 2022 $2.16 $2.34 $2.16 $2.34 207 600
Apr 01, 2022 $1.78 $2.25 $1.76 $2.20 2 147 479
Mar 31, 2022 $2.28 $2.46 $2.25 $2.28 327 009
Mar 30, 2022 $2.39 $2.50 $2.32 $2.32 211 655
Mar 29, 2022 $2.30 $2.47 $2.30 $2.37 139 000
Mar 28, 2022 $2.32 $2.40 $2.21 $2.33 179 200
Mar 25, 2022 $2.39 $2.55 $2.33 $2.36 238 600
Mar 24, 2022 $2.41 $2.45 $2.32 $2.38 62 500
Mar 23, 2022 $2.45 $2.50 $2.28 $2.42 284 900
Mar 22, 2022 $2.37 $2.46 $2.37 $2.43 67 027
Mar 21, 2022 $2.48 $2.52 $2.36 $2.38 137 255
Mar 18, 2022 $2.35 $2.49 $2.33 $2.49 289 222
Mar 17, 2022 $2.33 $2.38 $2.27 $2.35 246 800
Mar 16, 2022 $2.17 $2.35 $2.14 $2.30 373 300
Mar 15, 2022 $2.12 $2.23 $2.12 $2.16 180 300
Mar 14, 2022 $2.15 $2.15 $2.08 $2.10 100 700
Mar 11, 2022 $2.11 $2.17 $2.10 $2.11 56 500
Mar 10, 2022 $2.16 $2.19 $2.08 $2.13 111 300
Mar 09, 2022 $2.16 $2.23 $2.12 $2.21 112 500
Mar 08, 2022 $2.07 $2.18 $2.03 $2.12 158 400
Mar 07, 2022 $1.99 $2.10 $1.95 $2.07 178 800
Mar 04, 2022 $1.99 $2.06 $1.99 $2.04 126 700
Mar 03, 2022 $2.00 $2.08 $1.99 $2.01 62 500
Mar 02, 2022 $2.01 $2.06 $1.91 $2.02 155 200
Click to get the best stock tips daily for free!

About ARCA biopharma

ARCA biopharma ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase... ABIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT